marketshareAI

Oxf Nanopore Technologies

ONTHealthcare
218.60GBX
3.31%
Market Cap
2.10B
Volume
685.65k
19% of avg
P/E Ratio
-0.15
EPS (TTM)
-14.43
Beta
0.9
Day Range
211.60p - 219.20p
52 Week Range
88.60p218.60p220.00p
218.60p

Upcoming Events

2 September 2025
Announcement of interim results for the six months ended 30 June 2025
High Impact Event
1 January 2026
Mandatory lead audit partner rotation
2026
PromethION Q expected to launch
31 December 2026
CEO Gordon Sanghera to step down
2027
Target year for adjusted EBITDA breakeven
High Impact Event
2028
Target year for becoming cash flow positive
High Impact Event
ONT
NEUTRAL

Oxford Nanopore Announces CEO Succession Plan

The biotechnology company has announced that its long-serving CEO will step down by the end of 2026, triggering a formal search for a successor.

ONT
NEUTRAL

Oxford Nanopore Reappoints Deloitte as Auditor

The biotechnology company has reappointed Deloitte as its external auditor, following a formal tender process.

ONT
NEUTRAL

Oxford Nanopore Commences Legal Action Against MGI Australia

The biotechnology company has launched legal proceedings against MGI Australia for alleged patent infringement.

ONT
NEUTRAL

Oxford Nanopore Announces Shareholder Dealings

The biotechnology company has announced a change in major shareholder holdings.

ONT
GOOD

Oxford Nanopore Delivers Strong H1 Performance, Reaffirms Full Year Outlook

The biotechnology company reported robust first half results, with revenue up 25% and improving profitability, as it continues to make progress in its key markets.

ONT
NEUTRAL

Oxford Nanopore Director Purchases Shares Under SIP

The chief financial officer of the biotechnology company has purchased shares under the firm's share incentive plan.

ONT
NEUTRAL

Oxford Nanopore Technologies Publishes 2024 Sustainability Report

The biotechnology company has published its 2024 Sustainability Report, providing an update on its environmental and social initiatives.

ONT
NEUTRAL

Oxford Nanopore Announces Holding Change

The biotechnology company has announced a change in its major shareholder, with EIT Oxford Holdings, LLC increasing its stake to over 16%.

ONT
NEUTRAL

Oxford Nanopore Announces Major Shareholding Change

The biotechnology company has announced a change in major shareholding, with a US-based investment firm increasing its stake in the business.

ONT
NEUTRAL

Oxford Nanopore Director Increases Shareholding

The Chief Financial Officer of the biotechnology company has purchased additional shares through the company's Share Incentive Plan.